MedPath

Clinical study on feibi granule in treating patients with coal worker's pneumoconiosis in remission stage

Phase 1
Conditions
coal-worker's pnuemoconiosis
Registration Number
ITMCTR2200006865
Lead Sponsor
Fangshan Hospital, Beijing University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1)The coal workers' pneumoconiosis patients of stage I, II and III diagnosed by the occupational disease appraisal institution
(2)Meeting the criteria for the remission period
(3)It is in accordance with the diagnostic standard of syndrome of deficiency of lung-qi and obstruction of collaterals by phlegm and blood stasis
(4)Older than 18 years
(5)Agree to participate in the study and sign the informed consent.

Exclusion Criteria

(1)Patients report being pregnant/lactating
(2)Patients report with mental illness
(3)Patients report that they are complicated with respiratory failure, cor pulmonale, pulmonary-cerebral syndrome and severe pulmonary infection
(4)Patients with other diseases need to take other traditional Chinese medicine preparations for more than 4 weeks
(5)Patients report being enrolled in other clinical trials
(6)Patients report allergic constitution or drug allergy to the subject.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the modified British Medical Research Council(mMRC);
Secondary Outcome Measures
NameTimeMethod
TCM symptom integral scale;Human surfactant protein D;the MOS item short from health survey, SF-36;Human surfactant protein A;Chest computed tomography;Six-minute walk test;Pulmonary function;
© Copyright 2025. All Rights Reserved by MedPath